Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic
This decision analytical modeling study found that the OncCOVID web-based application can quantitatively aid in the resource allocation of individualized treatment for patients with cancer during the COVID-19 global pandemic.
Source:
JAMA Oncology
Resource links:
SPS commentary:
Editorial applauds the authors for developing a more personalised approach to decision-making that is based on data rather than consensus opinion. It cautions however that estimates from the OncCOVID model should be used with some degree of caution, and the model’s risk parameters should be updated as new information emerges to reduce uncertainty and increase the accuracy of the model’s estimates.